Holt, Rune
Yahyavi, Sam Kafai
Kooij, Ireen
Andreassen, Christine Hjorth
Andersson, Anna-Maria
Juul, Anders
Jørgensen, Niels
Blomberg Jensen, Martin
Funding for this research was provided by:
Righospitalet, Cophenhagen. Denmark
Novo Nordisk Fonden
Aase og Ejnar Danielsens Fond
Danmarks Frie Forskningsfond
Article History
Received: 13 May 2022
Accepted: 13 February 2023
First Online: 28 February 2023
Declarations
:
: The trial was approved by the Danish Medicines Agency (approval no. 2010-024588-42), the Danish National Committee on Health Research Ethics (approval no. H-4-2010-138), and the Danish Data Protection Agency (approval no. 2010124801) and monitored by the Good Clinical Practice (GCP) Unit, Copenhagen University Hospitals. Informed consent was obtained from all participants.
: Not applicable.
: The authors declare that they have no competing interests.